Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent--application to a human single-chain Fv fragment.
暂无分享,去创建一个
K. Tsumoto | H. Kondo | I. Kumagai | M. Uchikawa | T. Juji | K Tsumoto | I Kumagai | K Shinoki | H Kondo | M Uchikawa | T Juji | K. Shinoki
[1] Wetlaufer Db,et al. Formation of three-dimensional structure in proteins. I. Rapid nonenzymic reactivation of reduced lysozyme. , 1970, Biochemistry.
[2] Thomas E. Creighton,et al. Protein structure : a practical approach , 1997 .
[3] E. Pohl,et al. Contribution of the intramolecular disulfide bridge to the folding stability of REIv, the variable domain of a human immunoglobulin kappa light chain. , 1996, Folding & design.
[4] D. Segal,et al. Correct disulfide pairing and efficient refolding of detergent-solubilized single-chain Fv proteins from bacterial inclusion bodies. , 1995, Molecular immunology.
[5] R. Webster,et al. Recombinant antineuraminidase single chain antibody: Expression, characterization, and crystallization in complex with antigen , 1993, Proteins.
[6] César Milstein,et al. Man-made antibodies , 1991, Nature.
[7] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[8] A. Rees,et al. Expression of mouse immunoglobulin light and heavy chain variable regions in Escherichia coli and reconstitution of antigen-binding activity. , 1990, Protein engineering.
[9] M. Goldberg,et al. The renaturation of reduced chymotrypsinogen A in guanidine HCl. Refolding versus aggregation. , 1978, The Journal of biological chemistry.
[10] K. Tsumoto,et al. Effect of the order of antibody variable regions on the expression of the single-chain HyHEL10 Fv fragment in E. coli and the thermodynamic analysis of its antigen-binding properties. , 1994, Biochemical and biophysical research communications.
[11] R. Bruccoleri,et al. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[12] R. Glockshuber,et al. The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli. , 1992, Biochemistry.
[13] G. Winter,et al. Molecular evolution of proteins on filamentous phage. Mimicking the strategy of the immune system. , 1992, Journal of Biological Chemistry.
[14] G. Winter,et al. Making antibodies by phage display technology. , 1994, Annual review of immunology.
[15] A. Skerra. Bacterial expression of immunoglobulin fragments. , 1993, Current opinion in immunology.
[16] Kumagai Izumi,et al. Synthesis and expression of a DNA encoding the Fv domain of an anti-lysozyme monoclonal antibody, HyHEL10, in Streptomyces lividans , 1993 .
[17] K. Tsumoto,et al. Construction of mono- and bivalent human single-chain Fv fragments against the D antigen in the Rh blood group: multimerization effect on cell agglutination and application to blood typing. , 1998, Protein engineering.
[18] T Prospero,et al. "Diabodies": small bivalent and bispecific antibody fragments. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Plückthun. Mono‐ and Bivalent Antibody Fragments Produced in Escherichia coli: Engineering, Folding and Antigen Binding , 1992, Immunological reviews.
[20] K Watanabe,et al. Contribution to antibody-antigen interaction of structurally perturbed antigenic residues upon antibody binding. , 1994, The Journal of biological chemistry.
[21] Y. Goto,et al. The role of the intrachain disulfide bond in the conformation and stability of the constant fragment of the immunoglobulin light chain. , 1979, Journal of biochemistry.
[22] R. Rudolph,et al. Renaturation, Purification and Characterization of Recombinant Fab-Fragments Produced in Escherichia coli , 1991, Bio/Technology.
[23] S. Moestrup,et al. Receptor‐binding domain of human α2‐macroglobulin Expression, folding and biochemical characterization of a high‐affinity recombinant derivative , 1994, FEBS letters.
[24] K. Kuwajima,et al. Effects of amino acid substitutions in the hydrophobic core of alpha-lactalbumin on the stability of the molten globule state. , 1995, Protein engineering.
[25] K Watanabe,et al. Role of Tyr Residues in the Contact Region of Anti-lysozyme Monoclonal Antibody HyHEL10 for Antigen Binding (*) , 1995, The Journal of Biological Chemistry.
[26] T. Ueda,et al. Effective renaturation of reduced lysozyme by gentle removal of urea. , 1995, Protein engineering.
[27] K. D. Hardman,et al. Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coli. , 1991, Biochemistry.
[28] G. Winter,et al. Phage antibodies: filamentous phage displaying antibody variable domains , 1990, Nature.
[29] A. Plückthun,et al. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding. , 1997, Journal of molecular biology.
[30] K. Nielsen,et al. Expression and refolding of a high‐affinity receptor binding domain from rat α 1‐macroglobulin , 1995 .
[31] D. Givol,et al. Cloning and expression of the variable regions of mouse myeloma protein MOPC315 in E. coli: recovery of active FV fragments. , 1992, Molecular immunology.
[32] W. Harris,et al. Spontaneous assembly of bivalent single chain antibody fragments in Escherichia coli. , 1994, Molecular immunology.
[33] Y. Goto,et al. Formation of the intrachain disulfide bond in the constant fragment of the immunoglobulin light chain. , 1981, Journal of molecular biology.